製品: NQO2 Antibody
カタログ: DF7342
タンパク質の説明: Rabbit polyclonal antibody to NQO2
アプリケーション: WB IHC
Cited expt.: WB
反応性: Human, Mouse, Rat
予測: Pig, Horse, Rabbit, Dog, Chicken
分子量: 26kDa(Observed); 26kD(Calculated).
ユニプロット: P16083
RRID: AB_2839280

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(83%), Horse(91%), Rabbit(100%), Dog(100%), Chicken(91%)
クローナリティ:
Polyclonal
特異性:
NQO2 Antibody detects endogenous levels of total NQO2.
RRID:
AB_2839280
引用形式: Affinity Biosciences Cat# DF7342, RRID:AB_2839280.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

DHQV; DIA6; EC 1.10.99.2; MGC94180; NAD(P)H dehydrogenase quinone 2; NAD(P)H menadione oxidoreductase 1 dioxin inducible 2; NAD(P)H menadione oxidoreductase 2 dioxin inducible; NMOR2; NQO 2; NQO2; NQO2_HUMAN; NRH dehydrogenase [quinone] 2; NRH dehydrogenase; NRH:quinone oxidoreductase 2; OTTHUMP00000015948; OTTHUMP00000015949; OTTHUMP00000015953; Ox 2; Ox2; QR2; Quinone; Quinone reductase 2; Ribosyldihydronicotinamide dehydrogenase [quinone]; Ribosyldihydronicotinamide dehydrogenase;

免疫原

免疫原:

A synthesized peptide derived from human NQO2, corresponding to a region within N-terminal amino acids.

Uniprot:
遺伝子(ID):
タンパク質の説明:
NQO2 (EC 1.10.99.2) is a flavoprotein that catalyzes the 2-electron reduction of various quinones, redox dyes, and the vitamin K menadione. NQO2 predominantly uses dihydronicotinamide riboside (NRH) as the electron donor (summary by Wu et al., 1997 [PubMed 9367528]).
タンパク質配列:
MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNLEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Rabbit
100
Dog
100
Horse
91
Chicken
91
Pig
83
Bovine
75
Sheep
75
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

研究背景

機能:

The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.

細胞の位置付け:

Cytoplasm.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
タンパク質ファミリー:

Belongs to the NAD(P)H dehydrogenase (quinone) family.

参考文献

1). Homeostatic Shrinkage of Dendritic Spines Requires Melatonin Type 3 Receptor Activation During Sleep. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024 (PubMed: 39119847) [IF=15.1]

Application: IF/ICC    Species: Rat    Sample:

Figure 1 Selective expression of MT3Rs in MEC stellate neurons and elevated levels of melatonin within the MEC during the inactive phase. a) Representative images showing the expression of MT1Rs and MT2Rs in the MEC. Scale bar: 100 µm. b) Representative images showing the expression of MT3Rs in the reelin+ stellate neurons and calbindin+ pyramidal neurons of the MEC. Scale bar: 100 µm. c) Percentage of reelin+ stellate neurons and calbindin+ pyramidal neurons that were positive for MT3Rs (mean ± SEM). Mann-Whitney Rank Sum Test, **P < 0.01, n = 6 sections from 3 rats. d) Concentration of melatonin in the pineal gland tissue at 4 time points (10 A.M. and 11 A.M. represent inactive phase, 10 P.M. and 11 P.M. represent active phase). e) Bar graphs with overlaid dot plots showing the average concentration of melatonin in the pineal gland tissue during the day (10 A.M. and 11 A.M.) and night (10 P.M. and 11 P.M.) (mean ± SEM). Welch's t-test, *P < 0.05, n = 9 rats for each group. f) Concentration of CSF melatonin taken through the foramen magnum at 4 time points (10 A.M., 11 A.M., 10 P.M., and 11 P.M.). g) Bar graphs with overlaid dot plots showing the average concentration of the CSF melatonin during the day (10 A.M. and 11 A.M.) and night (10 P.M. and 11 P.M.) (mean ± SEM). Mann-Whitney Rank Sum Test, **P < 0.01, n = 10 rats for each group. h) Melatonin measurements in tissue homogenates of the MEC at 4 time points (10 A.M., 11 A.M., 10 P.M., and 11 P.M.). i) Bar graphs with overlaid dot plots showing the average concentration of melatonin in the MEC tissue homogenates during the day (10 A.M. and 11 A.M.) and night (10 P.M and 11 P.M.) (mean ± SEM). Welch's t-test, *P < 0.05, n = 15 sample points, inactive phase, n = 16 sample points, active phase, each sample point consists of bilateral MEC tissue samples from 3 rats. j) Images showing AANAT expression levels in the MEC (left), Scale bar: 50 µm. Bar graphs with overlaid dot plots showing the AANAT expression levels at active and inactive phases (mean ± SEM). Mann-Whitney Rank Sum Test, **P < 0.01, n = 12 sections from 4 rats, 12 A.M., n = 12 sections from 4 rats, 12 P.M. (right). k) Immunoblot analysis of AANAT expression levels at active and inactive phase (mean ± SEM). Student's t-test, *P < 0.05, n = 4 rats, 12 A.M., n = 4 rats, 12 P.M. MT1Rs, Melatonin type 1 receptors; MT2Rs, Melatonin type 2 receptors; MT3Rs, Melatonin type 3 receptors; MEC, medial entorhinal cortex; CSF, cerebrospinal fluid; AANAT, aralkylamine N-acetyltransferase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

2). Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity. MOLECULAR IMMUNOLOGY, 2020 (PubMed: 32438202) [IF=3.2]

Application: WB    Species: mouse    Sample: BV3 cells

Fig. 3. |Idebenone inhibited NLRP3 signaling in BV2 cells under OGD/R conditions. (a) Immunoblot analysis of NQO1, NQO2, NOX2 and NLRP3 signaling in BV2 cells with or without treatment of idebenone after OGD/R.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.